Dietary and genetically-induced oxidative stress alter tau phosphorylation: Influence of folate and apolipoprotein E deficiency

Journal of Alzheimer's Disease

Volumn 9, Issue 4, 2006, Pages 399-405

  Chan, Amy ^a   Shea, Thomas B ^a  

^a University of Massachusetts Lowell   (United States)

Author keywords

Alzheimer disease; Apolipoprotein E; Folate; Tau phosphorylation; Vitamin E

Indexed keywords

APOLIPOPROTEIN E; FOLIC ACID; IRON; ISOPROTEIN; MICROTUBULE PROTEIN; MONOCLONAL ANTIBODY; S ADENOSYLMETHIONINE; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; FOLIC ACID DEFICIENCY; HOMOZYGOTE; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOREACTIVITY; MOUSE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 33747429095     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9405     Document Type: Article

References (65)

1. C. Berr, Oxidative stress and cognitive impairment in the elderly, J Nutr Health Aging 6 (2002), 261-266.
2. D.A. Butterfield, A. Castegna, C.M. Lauderback and J. Drake, Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death, Neurobiol Aging 23 (2002), 655-664.
3. R.A. Floyd and K. Hensley, Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases, Neurobiol Aging 23 (2002), 795-807.
4. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K. Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen and M.A. Smith, Oxidative damage is the earliest event in Alzheimer disease, J Neuropathol Exp Neurol 60 (2001), 759-767.
5. G. Perry, A.D. Cash and M.A. Smith, Alzheimer Disease and Oxidative Stress, J Biomed Biotechnol 2 (2002), 120-123.
6. G. Perry, A. Nunomura, K. Hirai, X. Zhu, M. Prez, J. Avila, R.J. Castellani, C.S. Atwood, G. Aliev, L.M. Sayre, A. Takeda and M.A. Smith, Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med 33 (2002), 1475-1479.
7. S.W. Barger and A.D. Harmon, Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E, Nature 388 (1997), 878-881.
8. Y. Chen, L. Lomnitski, D.M. Michaelson and E. Shohami, Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury, Neuroscience 80 (1997), 1255-1262.
9. J. Hu, M.J. LaDu and L.J. Van Eldik, Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation, J Neurochem 71 (1998), 1626-1634.
10. D. Pratico, J. Rokach and R.K. Tangirala, Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation, J Neurochem 73 (1999), 736-741.
11. H. Sheng, D.T. Laskowitz, G.B. Mackensen, M. Kudo, R.D. Pearlstein and D.S. Warner, Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse, Stroke 30 (1999), 1118-1124.
12. J. Mutter, J. Naumann, C. Sadaghiani, R. Schneider and H. Walach, Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator, Neuroendocrinol Lett 25 (2004), 331-339.
13. G.W. Rebeck, M. Kindy and M.J. LaDu, Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3, J Alz Dis 4 (2002), 145-154.
14. G.S. Huang, S.M. Yang, M.Y. Hong, P.C. Yang and Y.C. Liu, Differential gene expression of livers from ApoE deficient mice, Life Sci 68 (2000), 19-28.
15. C. Ramassamy, D. Averill, L. Beffert, L. Throux, S. Lussier-Cacan, J.S. Cohn, Y. Christen, J. Schoofs and J. Davignon, Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype, Free Rad Biol Med 27 (1999), 544-553.
16. C. Ramassamy, P. Krzywkowski, D. Averill, S. Lussier-Cacan, L. Throux, Y. Christen, J. Sch Davignon and J. Poirier, Impact of apolipoprotein E deficiency on oxidative insults and antioxidant levels in the brain, Mol Brain Res 86 (2002), 76-83.
17. I. Veinbergs, M. Mallory, Y. Sagara and E. Masliah, Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice, Eur J Neurosci 12 (2000), 4541-4546.
18. I. Ferrer, T. Gomez-Isla, B. Puig, M. Freixes, E. Ribe, E. Dalfo and J. Avila, Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies, Curr Alzheimer Res 2 (2005), 3-18.
19. F.M. LaFerla and S. Oddo, Alzheimer's disease: Abeta, tau and synaptic dysfunction, Trends Mol Med 11(4) (2005), 170-176.
20. M. Kobayashi, K. Ishiguro, Y. Katoh-Fukui, M. Yokoyama and S.C. Fujita, Phosphorylation state of tau in the hippocampus of apolipoprotein E4 and E3 knock-in mice, Neuroreport 14(5) (15 Apr. 2003), 699-702.
21. W.J. Brecht, F.M. Harris, S. Chang, I. Tesseur, G.Q. Yu, Q. Xu, J. Dee Fish, T. Wyss-Coray, M. Buttini, L. Mucke, R.W. Mahley and Y. Huang, Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice, J Neurosci 24(10) (10 Mar. 2004), 2527-2534.
22. X. Wang, P. Luebbe, E. Gruenstein and F. Zemlan, Apolipoprotein E (ApoE) peptide regulates tau phosphorylation via two different signaling pathways, J Neurosci Res 51(5) (1 Mar. 1998), 658-665.
23. L. Mercken and J.P. Brion, Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E, Neuroreport 6(17) (27 Nov. 1995), 2381-2384
24. R.M. Lane and M.R. Farlow, Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease, J Lipid Res 46(5) (May, 2005), 949-968.
25. N. Ohkubo, Y.D. Lee, A. Morishima, T. Terashima, S. Kikkawa, M. Tohyama, M. Sakanaka, J. Tanaka, N. Maeda, M.P. Vitek and N. Mitsuda, Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade, FASEB J 17 (2003), 295-297.
26. A. Rahman, S. Akterin, A. Flores-Morales, M. Crisby, M. Kivipelto, M. Schultzberg and A. Cedazo-Minguez, High cholesterol diet induces tau hyperphosphorylation in apolipoprotein E deficient mice, FEBS Lett 579(28) (21 Nov. 2005), 6411-6416.
27. T.B. Shea and E. Rogers, Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: augmentation by vitamin E, Mol Brain Res 108 (2002), 1-6.
28. F. Tchantchou, M. Graves, D. Ashline, A. Morin, A. Pimenta, D. Ortiz, E. Rogers and T.B. Shea, Increased transcription and activity of glutathione synthase in response to deficiencies in folate, vitamin E and apolipoprotein E, J Neurosci Res 75 (2004), 508-155.
29. F. Tchantchou, M. Graves, D. Ortiz and T.B. Shea, S-adenosyl methionine: a link between nutritional and genetic risk factors in Alzheimer's disease, J Nutri Health Aging (2006), in press.
30. M.M. Kawashima, N. Oshima, H. Ogata, H. Yamaguchi, M. Yoshmiura, S. Sugihara and Y. Iharo, Effect of Apolipoprotein E Allele E4 on the initial phase of amyloid beta-protein accumulation in the human brain, Am Jour Path 157(6) (2000), 2093-2099.
31. S.G. Greenberg and P. Davies, A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis, Proc Natl Acad Sci USA 87 (1990), 5827-5831.
32. K.S. Kosik, J.E. Crandall, E.J. Mufson and R.L. Neve, Tau in situ hybridization in normal and Alzheimer brain: localization in the somatodendritic compartment, Ann Neurol 26 (1989), 352-361.
33. J.T. Egana, C. Zambrano, M.T. Nunez, C. Gonzalez-Billault and R.B. Maccioni, Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures, Biometals 16(1) (Mar. 2003), 215-223.
34. M.A. Lovell, S. Xiong, C. Xie, P. Davies and W.R. Markesbery, Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3, J Alzheimers Dis 6(6) (Dec. 2004), 659-671.
35. A. Gomez-Ramos, J. Diaz-Nido, M.A. Smith, G. Perry and J. Avila, Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells, J Neurosci Res 71(6) (15 Mar. 2003), 863-870.
36. F. Malchiodi-Albedi, T.C. Petrucci, B. Picconi, F. Iosi and M. Falchi, Protein phosphatase inhibitors induce modification of synapse structure and tau hyperphosphorylation in cultured rat hippocampal neurons, J Neurosci Res 48(5) (1 Jun. 1998), 425-438.
37. T.D. Garver, K.A. Harris, R.A. Lehman, V.M. Lee, J.Q. Trojanowski and M.L. Billingsley, Tau phosphorylation in human, primate, and rat brain: evidence that a pool of tau is highly phosphorylated in vivo and is rapidly dephosphorylated in vitro, J Neurochem 63(6) (Dec. 1994), 2279-2287.
38. E.S. Matsuo, R.W. Shin, M.L. Billingsley, A. Van deVoorde, M. O'Connor, J.Q. Trojanowski and V.M. Lee, Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau, Neuron 13(1994), 989-1002.
39. Q. Liu, M.A. Smith, J. Avila, J. DeBernardis, M. Kansal, A. Takeda, X. Zhu, A. Nunomura, K. Honda, P.I. Moreira, C.R. Oliveira, M.S. Santos, S. Shimohama, G. Aliev, J. de la Torre, H.A. Ghanbari, S.L. Siedlak, P.L. Harris, L.M. Sayre and G. Perry, Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations, Free Radic Biol Med 38(6) (15 Mar. 2005), 746-754.
40. B. Dozza, M.A. Smith, G. Perry, M. Tabaton and P. Strocchi, Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells, J Neurochem 89(5) (Jun. 2004), 1224-1232.
41. F.M. Harris, W.J. Brecht, Q. Xu, R.W. Mahley and Y. Huang, Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signalregulated kinase: modulation by zinc, J Biol Chem 279 (2004), 44795-44801.
42. C. Ramassamy, D. Averill, U. Beffert, L. Theroux, S. Lussier-Cacan, J.S. Cohn, Y. Christen, A. Schoofs, J. Davignon and J. Poirier, Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain, Neurobiol Dis 7 (2000), 23-37.
43. T.B. Shea, E. Rogers, D. Ashline, D. Ortiz, N. Duarte, T.A. Wilson, R.J. Nicolosi and M.-H. Sheu, Vitamin E deficiency does not induce compensatory antioxidant increases in central nervous system tissue of apolipoprotein E-deficient mice, J Alz Dis 4 (2003), 1-6.
44. F. Tchantchou, M. Graves, E. Rogers, D. Ortiz and T.B. Shea, Dietary supplementation with 3-deaza adenosine, N-acetyl cysteine and S-adenosyl methionine provide neuroprotection against multiple consequences of vitamin deficiency and oxidative challenge: Relevance to age-related neurodegeneration, Neuromol Med 6 (2005), 93-104.
45. P. Ho, D. Ashline, S. Dhitavat, S. Collins, E. Rogers and T.B. Shea, Folate Deprivation Induces Neurodegeneration: Roles Of Oxidative Stress And Increased Homocysteine, Neurobiol Dis 14(1) (2003), 32-42.
46. I. Genis, A. Fisher and D.M. Michaelson, Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment, J Neurochem 72 (1999), 206-213.
47. A. Chan, F. Tchantchou, V. Graves, R. Rozen and T.B. Shea, Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression, Proc Int Alz Ass (2006), in press.
48. C.M. Cheng, V. Tseng, J. Wang, D. Wang, L. Matyakhina and C.A. Bondy, Tau is hyperphosphorylated in the insulin-like growth factor-I null brain, Endocrinology 146(12) (Dec. 2005), 5086-5091.
49. H. Nakashima, T. Ishihara, O. Yokota, S. Terada, J.Q. Trojanowski, V.M. Lee and S. Kuroda, Effects of alpha-tocopherol on an animal model of tauopathies, Free Radic Biol Med 37(2) (Jul. 2004), 176-186.
50. H.G. Lee, G. Perry, P.I. Moreira, M.R. Garrett, Q. Liu, X. Zhu, A. Takeda, A. Nunomura and M.A. Smith, Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends Mol Med 11(4) (Apr. 2005), 164-169.
51. P.I. Moreira, C.R. Oliveira, M.S. Santos, A. Nunomura, K. Honda, X. Zhu, M.A. Smith and G. Perry, A second look into the oxidant mechanisms in Alzheimer's disease, Curr Neurovasc Res 2(2) (Apr. 2005), 179-184.
52. A.C. Alonso, I. Grundke-Iqbal and K. Iqbal, Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules, Nat Med 2 (1996), 783-787.
53. A. Ebneth, R. Godemann, K. Stamer, S. Illenberger, B. Trinczek and E. Mandelkow, Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease, J Cell Biol 143 (1998), 777-794.
54. A. Salehi, J.D. Delcroix and W.C. Mobley, Traffic at the intersection of neurotrophic factor signaling and neurodegeneration, Trends Neurosci 26 (2003), 73-80.
55. K. Spittaels, C. Van den Haute, J. Van Dorpe, K. Bruynseels, K. Vandezande, I. Laenen, H. Geerts, M. Mercken, R. Sciot, A. Van Lommel, R. Loos and F. Van Leuven, Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein, Am J Pathol 155 (1999), 2153-2165.
56. K. Stamer, R. Vogel, E. Thies, E. Mandelkow and E.M. Mandelkow, Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress, J Cell Biol 156 (2002), 1051-1063.
57. R. Morsch, W. Simon and P.D. Coleman, Neurons may live for decades with neurofibrillary tangles, J Neuropathol Exp Neurol 58 (1999), 188-197.
58. T. Gomez-Isla, R. Hollister, H. West, S. Mui, J.H. Growdon, R.C. Petersen, J.E. Parisi and B.T. Hyman, Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease, Ann Neurol 41 (1997), 17-24.
59. J.J. Kril, S. Patel, A.J. Harding and G.M. Halliday, Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation, Acta Neuropathol (Berl) 103 (2002), 370-376.
60. M. Broe, C.E. Shepherd, E.A. Milward and G.M. Halliday, Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies, Acta Neuropathol (Berl) 101 (2001), 616-624.
61. N.Y. Calingasan, K. Uchida and G.E. Gibson, Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease, J Neurochem 72 (1999), 751-756.
62. M. Perez, R. Cuadros, M.A. Smith, G. Perry and J. Avila, Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal, FEBS Lett 486 (2000), 270-274.
63. M. Perez, F. Hernandez, A. Gomez-Ramos, M. Smith, G. Perry and J. Avila, Formation of aberrant phosphotau fibrillar polymers in neural cultured cells, Eur J Biochem 269 (2002), 1484-1489.
64. A. Takeda, M.A. Smith, J. Avila, A. Nunomura, S.L. Siedlak, X. Zhu, G. Perry and L.M. Sayre, In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification, J Neurochem 75 (2000), 1234-1241.
65. M.A. Smith, G. Casadesus, J.A. Joseph and G. Perry, Amyloid-β and tau serve antioxidant functions in the aging and Alzheimer brain, Free Radic Biol Med 33 (2002), 1194-1199.